Cantor Fitzgerald Maintains Overweight on IREN, Lowers Price Target to $61

Benzinga Newsdesk www.benzinga.com Negative 82.5%

Neg 82.5% Neu 0% Pos 0%

Cantor Fitzgerald analyst Brett Knoblauch maintains IREN (NASDAQ:IREN) with a Overweight and lowers the price target from $82 to $61.